News >

Recognizing Secondary Malignancies in CLL

Angelica Welch
Published: Wednesday, Oct 25, 2017

Alessandra Ferrajoli, MD

Alessandra Ferrajoli, MD
As with many other tumor types, patients with chronic lymphocytic leukemia (CLL) are at risk for developing secondary malignancies.

, Ferrajoli, professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discussed the risks of developing secondary malignancies in patients with CLL.

OncLive: What is the occurrence of other cancers in patients with CLL?

Ferrajoli: In CLL, this is a time where major discoveries are happening, so patients are having a very long life expectancy and there are a lot of active treatments. We noticed that 1 of the most common causes of death of the patients with CLL is the development of other cancers. We are calling them other cancers because they are not necessarily the type of cancer that we see after a patient receives chemotherapy. This is a very small percentage; the majority of the cancers that patients with CLL have are cancers that are not normally associated with treatment.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication
x